Pediatric HIV disease: new developments in treatment and prevention.

Despite the continued increase in the number of HIV-1-infected children, there is optimism that with the prospective identification of HIV-1-infected pregnant women, the incidence of infection can be diminished through prevention of mother-to-child transmission both by use of antiretroviral agents as well as by improved obstetrical management. Also, insight into viral dynamics and the advent of more potent antiretroviral agents provides hope for better treatment strategies and thus the ability to slow disease progression of HIV-1-infected children.
AuthorsA J Melvin, L M Frenkel
JournalAIDS clinical review (AIDS Clin Rev) 1997-1998 Pg. 109-27 ISSN: 1045-2877 [Print] UNITED STATES
PMID9305446 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-HIV Agents
  • Zidovudine
  • AIDS-Related Opportunistic Infections (diagnosis, drug therapy, prevention & control)
  • Adolescent
  • Adult
  • Anti-HIV Agents (administration & dosage, therapeutic use)
  • Child
  • Child, Preschool
  • Female
  • HIV Infections (diagnosis, drug therapy, prevention & control)
  • HIV Seropositivity
  • HIV-1
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Pregnancy
  • Pregnancy Complications, Infectious (virology)
  • Viral Load
  • Zidovudine (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: